US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

170.54

-0.6200-0.36%

Post-market: 170.610.0700+0.04%19:59 EDT

Volume:7.32M

Turnover:1.25B

Market Cap:43.88B

PE:-12.00

High:170.98

Open:170.25

Low:169.20

Close:171.16

52wk High:176.60

52wk Low:133.73

Shares:257.32M

Float Shares:257.32M

Volume Ratio:1.26

T/O Rate:2.84%

Dividend:2.53

Dividend Rate:1.49%

EPS(TTM):-14.2170

EPS(LYR):-14.2170

ROE:-9.22%

ROA:1.03%

PB:1.28

PE(LYR):-12.00

Loading ...

Overview Company News Filings

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan

Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)

Hygeia Healthcare to Present 2026 Interim Results via Investor Call

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Al-Aqar Healthcare REIT Malaysia 2nd-Quarter 2026 Earnings Summary Table

IHH Healthcare's Attributable Profit Jumps 29% in Q2

MT Newswires Live

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS

Health Care Roundup: Market Talk

Austco Healthcare Delivers Record Revenue and Margin Gains in FY26

Austco Healthcare Profit Jumps 52% on Strong Revenue Growth

Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone

IHH Healthcare's 2QFY2026 patmi up 29% y-o-y

The Edge Singapore

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS

Promisia shareholders back acquisition and board fee increase at 2026 AGM

UBS Sticks to Their Buy Rating for Sigma Healthcare Ltd (S5YA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/XLV/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":170.54,"timestamp":1788206400000,"preClose":171.16,"halted":0,"volume":7317631,"hourTrading":{"tag":"盘后","latestPrice":170.61,"preClose":170.54,"latestTime":"19:59 EDT","volume":362499,"amount":61822362.4267,"timestamp":1788220764142,"change":0.07,"changeRate":0.00041,"amplitude":0.00645},"delay":0,"changeRate":-0.003622341668614189,"floatShares":257315324,"shares":257315324,"eps":-14.217021,"marketStatus":"Not Yet Opened","change":-0.62,"latestTime":"08-31 16:00:00 EDT","open":170.25,"high":170.98,"low":169.2,"amount":1247150144.49266,"amplitude":0.0104,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":171.16,"sharesOutstanding":265215324,"nav":171.198367,"aum":44094762846.38,"dividendRate":0.014854,"bidAskSpread":0.000125,"preHourTrading":{"tag":"盘前","latestPrice":170.495,"preClose":171.16,"latestTime":"09:29 EDT","volume":1898,"amount":323928.31952,"timestamp":1788182995075,"change":-0.665,"changeRate":-0.003885,"amplitude":0.013854},"postHourTrading":{"tag":"盘后","latestPrice":170.61,"preClose":170.54,"latestTime":"19:59 EDT","volume":362499,"amount":61822362.4267,"timestamp":1788220764142,"change":0.07,"changeRate":0.00041,"amplitude":0.00645},"volumeRatio":1.261303,"impliedVol":0.2452,"impliedVolPercentile":0.9482},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":257315324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":1.261303,"shares":257315324,"dividePrice":2.5332,"high":170.98,"amplitude":0.0104,"preClose":171.16,"low":169.2,"week52Low":133.725,"pbRate":"1.28","psRate":"66.62","week52High":176.595,"institutionHeld":0.7846,"latestPrice":170.54,"eps":-14.217021,"divideRate":0.014854,"volume":7317631,"delay":0,"ttmEps":-14.217021,"open":170.25,"prevYearClose":154.8,"prevWeekClose":171.16,"prevMonthClose":162.55,"prevQuarterClose":158.66,"fiveDayClose":174.7,"twentyDayClose":162.24,"sixtyDayClose":152.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XLV","amount":0.656252,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XLV","amount":0.59468,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.307823,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.304755,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662859610","title":"Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2662859610","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662859610?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832000,"startTime":"0","endTime":"0","summary":"HAIFA, Israel, Aug.  27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional (\"3D\") cell expansion platform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351959/11974/en/pluri-announces-pricing-of-3-3-million-registered-direct-offering-and-concurrent-private-placement-with-a-single-healthcare-focused-institutional-investor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XLV","BK4137","XBI","BK4588","CDMO","LU0029874061.USD","BK4585","BK4581","BK4139","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662163701","title":"Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662163701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662163701?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:50","pubTimestamp":1787827800,"startTime":"0","endTime":"0","summary":"DEER PARK, Ill., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351865/0/en/eton-pharmaceuticals-to-participate-at-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0683600562.USD","LU1069347547.HKD","LU2361045086.USD","BK4207","LU1267930227.SGD","LU0128526141.USD","LU0310799852.SGD","LU0310800379.SGD","LU0211328371.USD","LU0708994859.HKD","XBI","BK4137","LU1074936037.SGD","LU2461242641.AUD","LU0029864427.USD","IYF","LU1280957306.USD","LU0742534661.SGD","LU0128525929.USD","LABU","PGF","LU0289960550.SGD","LU0130517989.USD","LU0971096721.USD","FTXO","BK4582","LU0106831901.USD","LU0251131958.USD","LU0256863811.USD","LU0417517546.SGD","LU1894683264.USD","KBWB","BK4585","LU1894683348.USD","LU0029874061.USD","TFNS","XLV","LU0175139822.USD","LU1035773651.USD","BK4559","LU2361044949.HKD","LU0787776722.HKD","HCSG","LU0267386448.USD","LU0868494708.USD","LU1814569148.SGD","IE00B19Z3581.USD","LU0072461881.USD","LU0149725797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706801","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706801?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Immuneering (IMRX) w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","CANC","BBH","BK4137","PTH","LU0128526141.USD","IE00B4R5TH58.HKD","LABU","IE0009354923.USD","RVMD","XLV","BK4139","IE00BFTCPJ56.SGD","HCSG","IE0002141913.USD","IE0009355771.USD","LU0029874061.USD","IE00BJJMRZ35.SGD","BK4563","LU0109394709.USD","IE00B2B36J28.USD","IDNA","IMRX","IE00BJT1NW94.SGD","BK4581","LU0320765992.SGD","LU0889565916.HKD","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703205","title":"Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703205?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825420,"startTime":"0","endTime":"0","summary":"An announcement from Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) is now available. Hygeia Healthcare reported interim revenue of RMB1,961.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-lifts-profit-boosts-cash-flow-and-unveils-expanded-shareholder-return-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-lifts-profit-boosts-cash-flow-and-unveils-expanded-shareholder-return-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XLV","HCSG","LU0128526141.USD","LU0029874061.USD","BK4585","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703720","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703720?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NeoGenomics (NEO) and Medtronic (MDT). NeoGenomics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU1116320737.USD","LU1244550577.SGD","IE00BQXX3F31.USD","IE00BVYPNW00.USD","LU0162691827.USD","IE000M9KFDE8.USD","LU0012050646.USD","XBI","BK4566","LU0265550359.USD","LU2089283258.USD","LU0158827781.USD","BK4581","IE00BGHQF631.EUR","LU0029874061.USD","LU0211331839.USD","BK4196","IE00B3PB1722.GBP","LU0006306889.USD","NEO","HCSG","IE00B42XCP33.USD","LU0072461881.USD","LU1116320901.HKD","LU1244550494.USD","LU0211326839.USD","LU1989764748.USD","FBT","LU2028103732.USD","LU0208291251.USD","BK4137","BK4585","MDT","LU2089984988.USD","LU0432979614.USD","LU2023251221.USD","LU0128526141.USD","LU1989771016.USD","LU1291159041.SGD","IE00BFXG1179.USD","LU0496365809.HKD","XLV","LU1571399168.USD","LU0106261372.USD","LU1983299246.USD","IE00BVYPNV92.GBP","LU1506573853.SGD","LU1989764664.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662213703","title":"Hygeia Healthcare to Present 2026 Interim Results via Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2662213703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662213703?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:09","pubTimestamp":1787825368,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare Holdings Co., Ltd. ( ($HK:6078) ) just unveiled an update. Hygeia Healthcare Holdings Co., Ltd. has announced it will host a conf...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-to-present-2026-interim-results-via-investor-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hygeia-healthcare-to-present-2026-interim-results-via-investor-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","BK4585","BK4137","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708043","title":"China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708043","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708043?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:08","pubTimestamp":1787825320,"startTime":"0","endTime":"0","summary":"China's JW Therapeutics interim revenue rises 4.7% on Carteyva salesOverviewChina cell immunotherapy developer's interim revenue grew 4.7% yr/yr, driven by Carteyva salesGross profit margin improved t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","02126","LU0310799852.SGD","GLAM","IBB","PPH","01801","LU0949170772.SGD","IE0004445239.USD","IXJ","LU0868494617.USD","LU2362541513.USD","LU1934455863.HKD","JDOC","IE00BN8TJ469.HKD","LU0708994859.HKD","LU2237443382.USD","XLV","LU0859254822.USD","ABBV","REGN","IBBQ","LU0395794307.EUR","LU0463099449.HKD","RXL","LU1934455277.USD","CMI","FTXH","TBXU","IYH","TRUH","688331","LU0432979614.USD","MEDX","LU2237443978.SGD","VHT","LU1244550577.SGD","03692","IE00BVYPNV92.GBP","PJP","IE000SO60NU8.SGD","LU1037948897.HKD","LU2097828714.EUR","BBH","LU0943347566.SGD","BK1574","AGNG","FHLC","MADE","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662470872","title":"Al-Aqar Healthcare REIT Malaysia 2nd-Quarter 2026 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2662470872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662470872?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:04","pubTimestamp":1787825040,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                      32,969,000         28,840,000. PreTax Profit                15,797,000         15,953,000. Net Profit                   15,797,000         15,953,000. Earnings Per Share             1.88 Sen           1.90 Sen. Dividend                       1.76 Sen           1.73 Sen. Revenue                      65,933,000         58,026,000. PreTax Profit                33,104,000         31,748,000. Net Profit                   33,104,000         31,748,000. Earnings Per Share             3.94 Sen           3.78 Sen. Dividend                       3.69 Sen           3.47 Sen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8C8U.SI","IQRA","XLV","IVRA","BPRE","HCSG","MDIV","PSCF","REIX","RNTY","YLDW","CFA.SI","RJMG","DFRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770481","title":"IHH Healthcare's Attributable Profit Jumps 29% in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662770481?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:46","pubTimestamp":1787824019,"startTime":"0","endTime":"0","summary":"IHH Healthcare's  attributable profit to owners jumped 29% during the second quarter of the year to 573 million ringgit from 443 million ringgit a year earlier, according to a Thursday filing with the Malaysian Exchange.Earnings per share came in at 0.0648 ringgit compared with 0.0502 ringgit in the year-ago period.Revenue rose 12% year over year to 7.05 billion ringgit from 6.3 billion ringgit.The healthcare services provider declared an interim dividend of 0.055 ringgit per share for the period, payable by Oct. 30.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","XBI","HCSG","BK4585","XLV","BK6511","LABU","BK4581","Q0F.SI","BK4588","BK4137","LU0029874061.USD","BK6092"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774764","title":"China Approves J&J's Oral Psoriasis Pill, Says Drugmaker","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774764","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774764?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:47","pubTimestamp":1787820442,"startTime":"0","endTime":"0","summary":"China approves J&J's oral psoriasis pill, says drugmakerSHANGHAI, Aug 27 (Reuters)-Johnson & JohnsonJNJ.Nsaid on Thursday that its oral drug icotrokinra was approved in China for moderate-to-severe plaque psoriasis.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","LU0795875086.SGD","IE000MB6IJN5.SGD","LU0640476718.USD","LU1057294990.SGD","LU0162691827.USD","LU0689472784.USD","JNJ","LU2756315318.SGD","RXL","LU1061106388.HKD","BK4534","IE00BKVL7J92.USD","IHE","LU1935042991.SGD","IYH","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1043141396.HKD","FHLC","XLV","LU1732799900.SGD","LU0795875169.SGD","JDOC","GDOC","MEDX","BK4588","LU0426412945.USD","LU0683600562.USD","LU1059921491.USD","LU2129689605.HKD","BMED","LU1221951046.USD","IXJ","IE00BBT3K403.USD","LU1551013342.USD","LU1228905037.USD","LU0820561909.HKD","TRUH","LU1244550577.SGD","IE00BGHQF631.EUR","LU1162221912.USD","PJP","LU1032955483.USD","LU0466842654.USD","LU0689626769.HKD","VHT","IE00B19Z3B42.SGD","LU2236285917.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477411","title":"Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:47","pubTimestamp":1787820442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2129689514.USD","IE0002141913.USD","SG9999001176.USD","JNJ","IE00BLSP4239.USD","TRUH","LU0943347566.SGD","IE000MB6IJN5.SGD","LU0053666078.USD","LU1244550221.USD","LU2347655156.SGD","JDOC","LU1032466523.USD","LU1551013425.SGD","LU2505996681.GBP","BK4532","IHE","BK4588","IE00BDGV0183.EUR","IE00BN8TJ469.HKD","LU2471134523.USD","VHT","PJP","LU2896262040.SGD","IXJ","LU1244550494.USD","IE0002270589.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","FHLC","BMED","LU0994945656.USD","LU0640476718.USD","LU2592432038.USD","GDOC","IE00BVYPNV92.GBP","FTXH","IE00B42XCP33.USD","LU0882574055.USD","XLV","BK4568","LU1894683264.USD","LU1196500208.SGD","IE0009355771.USD","RXL","LU1066051498.USD","LU1506573853.SGD","IYH","MEDX","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771196","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771196","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771196?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:20","pubTimestamp":1787818800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0721 GMT - Novo Nordisk faces persistent concerns over the scope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0577902538.SGD","LU0762540952.USD","LU0648948544.HKD","LU2152927971.USD","LU0315178854.USD","LU0873338254.USD","LU0165289439.USD","LU2238330802.EUR","LU0211331839.USD","SG9999003826.SGD","LU1211504680.USD","BK6516","XLV","SG9999005177.SGD","LU0326948709.USD","LU0672654166.SGD","D05.SI","LU0823417737.USD","SG9999000475.SGD","LU0878005551.USD","LU1634259391.SGD","LU0048597586.USD","LU0543330483.HKD","BK6112","SG9999004220.SGD","LU0886674414.USD","LU1282649067.USD","SG9999001903.USD","BK6523","LU0011963245.USD","LU0588545490.SGD","LU0823038988.USD","SG9999008742.SGD","SGXZ58947870.SGD","XBI","BK4588","LU0210637038.USD","LU0061477393.USD","LU0577902454.USD","LU1282649810.SGD","SG9999003800.SGD","SG9999009443.AUD","LU0823417653.USD","SG9999000343.SGD","LU0823413587.USD","LU1497733631.SGD","SG9999004360.SGD","LU0955669360.SGD","LU0823413660.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662377970","title":"Austco Healthcare Delivers Record Revenue and Margin Gains in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662377970","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662377970?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:58","pubTimestamp":1787817490,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) has issued an announcement. Austco Healthcare reported record FY26 customer revenue of $94.2 million, up 16...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-delivers-record-revenue-and-margin-gains-in-fy26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-delivers-record-revenue-and-margin-gains-in-fy26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662777903","title":"Austco Healthcare Profit Jumps 52% on Strong Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662777903","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662777903?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:58","pubTimestamp":1787817482,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) has issued an announcement. Austco Healthcare Limited reported a 15.8% rise in revenue to $94.2 million for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-profit-jumps-52-on-strong-revenue-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-profit-jumps-52-on-strong-revenue-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158123171","title":"Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone","url":"https://stock-news.laohu8.com/highlight/detail?id=1158123171","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158123171?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:00","pubTimestamp":1787814046,"startTime":"0","endTime":"0","summary":"On August 27, the \"15th Five-Year Plan for Health Development in Fujian Province\" was officially released, outlining key initiatives for the upcoming period.Among the highlighted measures, the plan...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","VHT","WDNA","BK4581","BK4585","BK4588","XBI","IXJ","BK4550","HELX","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058303","title":"IHH Healthcare's 2QFY2026 patmi up 29% y-o-y","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058303","media":"The Edge Singapore ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058303?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:34","pubTimestamp":1787812483,"startTime":"0","endTime":"0","summary":"\"We remain confident on reaching double-digit ROE by 2028,\" says group CEO Dr Prem Kumar Nair","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BK6092","LABU","BK4588","Q0F.SI","XLV","BK6511","BK4581","XBI","HCSG","BK4585","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733417","title":"AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733417","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733417?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:01","pubTimestamp":1787810517,"startTime":"0","endTime":"0","summary":"AbbVie seeks EMA approval for Skyrizi subcutaneous induction in Crohn’s diseaseAbbVie filed with the EMA seeking approval for SKYRIZI subcutaneous induction in adults with moderately to severely activ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL4xK88y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620834.HKD","LU1989771016.USD","LU1003077747.HKD","JDOC","VHT","IE00BGHQF631.EUR","LU0472753341.HKD","LU1923622614.USD","SG9999001440.SGD","LU1037948897.HKD","FHLC","LU0708994859.HKD","LU2023251221.USD","LU1496350502.SGD","AGNG","LU0203347892.USD","IE0002270589.USD","LU2087621335.USD","LU2237443895.HKD","LU1244550221.USD","RXL","SG9999011175.SGD","GLAM","LU1718418525.SGD","LU2468319806.SGD","PPH","TRUH","LU2129689514.USD","LU0417517546.SGD","LU1934455863.HKD","IYH","LU0198837287.USD","LU1670628061.USD","MEDX","LU2433249047.HKD","SG9999015945.SGD","LU0965509010.AUD","XLV","LU0320765646.SGD","LU1934455277.USD","IE00BFTCPJ56.SGD","BK4566","BK4559","LU0861579265.USD","FTXH","IXJ","LU1093756325.SGD","PJP","LU0882574055.USD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778703","title":"Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778703?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUAC1ZNZW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1244550577.SGD","LU1989772840.SGD","LU1267930490.SGD","LU0256863811.USD","AGNG","FTXH","LU1162221912.USD","LU1244550221.USD","IXJ","LU0985320562.USD","LU2129689514.USD","PPH","LU0158827948.USD","LU1267930573.SGD","LU0795875169.SGD","IE0004445239.USD","IYH","LU0795875086.SGD","LU1236620834.HKD","LU1989771016.USD","LU2089283258.USD","LU2468319806.SGD","IE00BVYPNW00.USD","MEDX","JDOC","LU0203345920.USD","LU0511384066.AUD","GLAM","SG9999003800.SGD","LU1670628061.USD","BK4550","LU0949170772.SGD","PJP","RXL","LU0912757837.SGD","LU1585245621.USD","LU2237443895.HKD","LU0256863902.USD","LU0098860793.USD","LU0289739343.SGD","VHT","LU1551013342.USD","LU0310799852.SGD","FHLC","TRUH","BK4139","XLV","LU0965508806.USD","LU1244550494.USD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778957","title":"Promisia shareholders back acquisition and board fee increase at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778957","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:17","pubTimestamp":1787807834,"startTime":"0","endTime":"0","summary":"An update from Promisia Healthcare Limited ( ($NZ:PHL) ) is now available. Promisia Healthcare Limited has reported that all resolutions put to sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-shareholders-back-acquisition-and-board-fee-increase-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-shareholders-back-acquisition-and-board-fee-increase-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AGM","BK4588","XLV","BK4195","XBI","BK4229","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662572717","title":"UBS Sticks to Their Buy Rating for Sigma Healthcare Ltd (S5YA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662572717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662572717?lang=en_us&edition=fundamental","pubTime":"2026-08-27 12:15","pubTimestamp":1787804127,"startTime":"0","endTime":"0","summary":"UBS analyst Shaun Cousins maintained a Buy rating on Sigma Healthcare Ltd today and set a price target of A$3.40. Cousins covers the Consumer Cycli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-their-buy-rating-for-sigma-healthcare-ltd-s5ya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-their-buy-rating-for-sigma-healthcare-ltd-s5ya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":30,"pageCount":8,"totalSize":587,"code":"91000000","status":"200"}]}}